The Journal of clinical endocrinology and metabolism
Impact of Growth-promoting Therapies on Puberty, Growth, and Final Height in Classical 21-hydroxylase Deficiency.
Zehra Yavas Abali, Melek Yildiz, Saygin Abali, Ariorad Moniri, Firdevs Bas, Hasan Onal, Gizem Cilsaat, Guven Toksoy, Serap Turan, Sukran Poyrazoglu, Zehra Oya Uyguner, Ruveyde Bundak, Abdullah Bereket, Feyza Darendeliler, Tulay Guran
Published: 202510.1210/clinem/dgaf612
Abstract
CONTEXT: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency (21-OHD) poses significant growth challenges, including accelerated bone maturation, precocious puberty, and compromised final height (FH). Data on pubertal growth in large 21-O…
Preview only. Read the full abstract at the source